NCT04133584View on ClinicalTrials.gov

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

1,134

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

November 30, 2021

Conditions
Seasonal InfluenzaHand, Foot and Mouth Disease
Interventions
BIOLOGICAL

EV71 +SIV

Give 2 doses of EV71 +SIV, get 2 blood samples before the first dose and 28-43 days after the last dose.

BIOLOGICAL

EV71

Give 2 doses of EV71 , get 2 blood samples before the first dose and 28-43 days after the last

BIOLOGICAL

SIV

Give 2 doses of SIV , get 2 blood samples before the first dose and 28-43 days after the last

Trial Locations (1)

Unknown

Liandu Center for Disease Control and Prevention, Lishui

All Listed Sponsors
collaborator

China National Biotec Group Company Limited

INDUSTRY

lead

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

NCT04133584 - The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine | Biotech Hunter | Biotech Hunter